30 July 2026
Latham Advises on Private Credit Financing for Apex Infusion’s Partnership With SkyKnight Capital
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Stelios Saffos Lead | Latham & Watkins LLP | Partner | Capital Markets and Hybrid Capital | Not stated |
| Alfred Xue Lead | Latham & Watkins LLP | Partner | Banking & Private Credit | Not stated |
| Abhay Lele | Latham & Watkins LLP | Partner | Not stated | Not stated |
| Josh Holt | Latham & Watkins LLP | Partner | Not stated | Not stated |
| Julio Martinez Rivas | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Cynthia Yang | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Bora Bozkurt | Latham & Watkins LLP | Partner | tax | Not stated |
| James Aldred | Latham & Watkins LLP | Associate | tax | Not stated |
5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Not stated
- Counterparties
- Apex Infusion (Sell-side)
SkyKnight Capital, L.P. (Buy-side)
FFL Partners (Investor)